NU will design and develop a fiber-optic LEBS probe that would be capable of acquitting information about tissue nanoarchitecture and microvasculature. The probe is to be tested by Boston Medical Center investigators to identify patients at a higher risk for colorectal cancer.
|Effective start/end date||2/1/13 → 11/30/16|
- Boston Medical Center (BMC#3727//R01CA156186)
- National Cancer Institute (BMC#3727//R01CA156186)